疑难病杂志
疑難病雜誌
의난병잡지
JOURNAL OF DIFFICULT AND COMPLICATED CASES
2014年
10期
991-994
,共4页
李莉%周元丽%张雪晶%刘丽%王晓琳
李莉%週元麗%張雪晶%劉麗%王曉琳
리리%주원려%장설정%류려%왕효림
高血压%瑞舒伐他汀%血管活性物质%脉压指数%内膜中层厚度
高血壓%瑞舒伐他汀%血管活性物質%脈壓指數%內膜中層厚度
고혈압%서서벌타정%혈관활성물질%맥압지수%내막중층후도
Hypertension%Rosuvastatin%Vasoactive substance%Pulse pressure index%Intima-media thickness
目的评价瑞舒伐他汀钙对高血压患者血管活性物质、脉压指数(PPI)及颈动脉内膜中层厚度( IMT)的影响及相关性。方法选择高血压患者80例,随机分成观察组和对照组,每组各40例。观察组在原降压药物的基础上加服瑞舒伐他汀钙(10 mg/d),对照组则继续服用原降压药物不变,于治疗前及治疗1个月、6个月、12个月分别检测患者的血清高敏C反应蛋白(hs-CRP)、血同型半胱氨酸(Hcy)、血压、PPI及颈动脉IMT。结果2组治疗前血压、PPI、血清hs-CRP、Hcy及IMT比较差异无统计学意义( P >0帋.05)。与治疗前相比,2组治疗1个月后肱动脉的收缩压、PP均有明显的降低( P <0.05),而舒张压无显著改变;对照组PPI在治疗12个月后差异有统计学意义(P <0.05),观察组治疗1个月后PPI有明显的降低( P <0.05)。与对照组相比,观察组治疗6个月后收缩压、PP降低更明显( P <0.05),而PPI治疗1、6、12个月后与同期对照组相比差异均有统计学意义( P <0.05)。观察组治疗后血清hs-CRP、Hcy浓度及IMT均有明显的降低( P <0.05),与对照组相比,观察组hs-CRP治疗1、6、12个月后差异有统计学意义( P <00.5);Hcy治疗6、12个月后差异有统计学意义( P <0.05),IMT治疗6个月后差异有统计学意义( P <0.05)。相关性分析表明,PPI与血清hs-CRP、Hcy浓度及颈动脉IMT均呈正相关(分别为r =0.606、0.583、0.672, P <0.05)。结论瑞舒伐他汀能显著降低高血压患者血管活性物质水平,改善IMT并降低PPI,从而起到抑制炎性反应、缩小动脉粥样硬化斑块,改善血管弹性的作用。
目的評價瑞舒伐他汀鈣對高血壓患者血管活性物質、脈壓指數(PPI)及頸動脈內膜中層厚度( IMT)的影響及相關性。方法選擇高血壓患者80例,隨機分成觀察組和對照組,每組各40例。觀察組在原降壓藥物的基礎上加服瑞舒伐他汀鈣(10 mg/d),對照組則繼續服用原降壓藥物不變,于治療前及治療1箇月、6箇月、12箇月分彆檢測患者的血清高敏C反應蛋白(hs-CRP)、血同型半胱氨痠(Hcy)、血壓、PPI及頸動脈IMT。結果2組治療前血壓、PPI、血清hs-CRP、Hcy及IMT比較差異無統計學意義( P >0帋.05)。與治療前相比,2組治療1箇月後肱動脈的收縮壓、PP均有明顯的降低( P <0.05),而舒張壓無顯著改變;對照組PPI在治療12箇月後差異有統計學意義(P <0.05),觀察組治療1箇月後PPI有明顯的降低( P <0.05)。與對照組相比,觀察組治療6箇月後收縮壓、PP降低更明顯( P <0.05),而PPI治療1、6、12箇月後與同期對照組相比差異均有統計學意義( P <0.05)。觀察組治療後血清hs-CRP、Hcy濃度及IMT均有明顯的降低( P <0.05),與對照組相比,觀察組hs-CRP治療1、6、12箇月後差異有統計學意義( P <00.5);Hcy治療6、12箇月後差異有統計學意義( P <0.05),IMT治療6箇月後差異有統計學意義( P <0.05)。相關性分析錶明,PPI與血清hs-CRP、Hcy濃度及頸動脈IMT均呈正相關(分彆為r =0.606、0.583、0.672, P <0.05)。結論瑞舒伐他汀能顯著降低高血壓患者血管活性物質水平,改善IMT併降低PPI,從而起到抑製炎性反應、縮小動脈粥樣硬化斑塊,改善血管彈性的作用。
목적평개서서벌타정개대고혈압환자혈관활성물질、맥압지수(PPI)급경동맥내막중층후도( IMT)적영향급상관성。방법선택고혈압환자80례,수궤분성관찰조화대조조,매조각40례。관찰조재원강압약물적기출상가복서서벌타정개(10 mg/d),대조조칙계속복용원강압약물불변,우치료전급치료1개월、6개월、12개월분별검측환자적혈청고민C반응단백(hs-CRP)、혈동형반광안산(Hcy)、혈압、PPI급경동맥IMT。결과2조치료전혈압、PPI、혈청hs-CRP、Hcy급IMT비교차이무통계학의의( P >0지.05)。여치료전상비,2조치료1개월후굉동맥적수축압、PP균유명현적강저( P <0.05),이서장압무현저개변;대조조PPI재치료12개월후차이유통계학의의(P <0.05),관찰조치료1개월후PPI유명현적강저( P <0.05)。여대조조상비,관찰조치료6개월후수축압、PP강저경명현( P <0.05),이PPI치료1、6、12개월후여동기대조조상비차이균유통계학의의( P <0.05)。관찰조치료후혈청hs-CRP、Hcy농도급IMT균유명현적강저( P <0.05),여대조조상비,관찰조hs-CRP치료1、6、12개월후차이유통계학의의( P <00.5);Hcy치료6、12개월후차이유통계학의의( P <0.05),IMT치료6개월후차이유통계학의의( P <0.05)。상관성분석표명,PPI여혈청hs-CRP、Hcy농도급경동맥IMT균정정상관(분별위r =0.606、0.583、0.672, P <0.05)。결론서서벌타정능현저강저고혈압환자혈관활성물질수평,개선IMT병강저PPI,종이기도억제염성반응、축소동맥죽양경화반괴,개선혈관탄성적작용。
Objective To evaluate the effect of rosuvastatin calcium on vasoactive substances , pulse pressure index ( PPI) and carotid artery intima-media thickness ( IMT) in patients with essential hypertension .Methods Eighty hyperten-sive patients were randomly divided into the observation group of 40 cases, with the antihypertensive drug and rosuvastatin cal-cium 10 mg orally 1 time a day, 40 patients in control group only received the antihypertensive drug .Before treatment,after 1 months, 6 months and 12months of treatment , 2 groups of patient’s high sensitivity C reactive protein (hs-CRP), homocys-teine(Hcy),blood pressure,pulse pressure index and intima media thickness were measured and recorded .Results No statis-tical significance differences of before treatment blood pressure , PPI, serum hs-CRP, Hcy and IMT were found between the 2 groups ( P >0.05).Compared with before treatment, after 1 months of treatment, brachial artery systolic blood pressure, PP in the 2 groups were significantly decreased ( P <0.05), and diastolic blood pressure did not change significantly;after 12 months of treatment, the PPI in control group revealed statistical significance differences ( P <0.05), after 1 months of treat-ment, the observation group’s PPI significantly reduced ( P <0.05).Compared with the control group, after 6 months of treatment, the observation group’s PP and systolic blood pressure decreased more significantly ( P <0.05), and treatment for 1, 6, 12 months later, compared with the same period control group , PPI in the observation group had significant differ-ence ( P <0.05).The observation group after treatment ,serum hs -CRP, Hcy concentration and IMT were significantly de-creased ( P <0.05),compared with the control group,the observation group’s hs-CRP had significant differences at the treat-ment of 1,6,12 months ( P <0.05);after treatment for 6,12 months,Hcy in the observation group had statistical significance <br> difference ( P <0 K.05), treatment for 6 months, IMT also had significant difference ( P <0.05).Correlation analysis showed that PPI and serum hs-CRP, the concentration of Hcy and carotid artery IMT were positively correlated ( r =0.606, r = 0.583, r =0.672, P <0.05).Conclusion Rosuvastatin can significantly reduce the plasma vasoactive substances in hypertensive patients , improve IMT and reduce PPI , and thus inhibit the inflammatory reaction , reduce atherosclerotic plaque , improve blood vessel elasticity .